Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Crohn's and Colitis Center
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
McGuire DVAMC, GI (111N)
mi
from
Richmond, VA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Medstar Georgetown University Hospital (Patient Exams)
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling, Phase III
Updated: 12/31/1969
Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Trial
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
Status: Enrolling
Updated: 12/31/1969
Heartland Primary Care
mi
from
Kansas City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Status: Enrolling, Phase III
Updated: 12/31/1969
US1015
mi
from
Baltimore, MD
Click here to add this to my saved trials
Overactive Bladder Clinical Trial
Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Urogynecology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cytomegalovirus (CMV) Clinical Trial
Efficacy and Safety Study of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Hudson Valley Hematology Oncology
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovative Clinical Research Institute (ICRI)
mi
from
Whittier, CA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
Status: Enrolling, Phase I
Updated: 12/31/1969
Yale Cancer Center ; Medical Oncology
mi
from
New Haven, CT
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
Status: Enrolling, Phase I
Updated: 12/31/1969
Princess Margaret Hospital, Medical Oncology & Haematology
mi
from
Toronto,
Click here to add this to my saved trials
Oncology Clinical Trial
Optimizing Preventative Adjuvant Linac-Based Radiation: the OPAL Trial - Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ohio Health/Presbyterian MDA Radiation Treatment Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Optimizing Preventative Adjuvant Linac-Based Radiation: the OPAL Trial - Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
MD Anderson Cancer Center at Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling, Phase II
Updated: 3/30/2017
Radiant Research - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling, Phase II
Updated: 3/30/2017
Family Practice Specialists - Radiant
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
EDS in Ataxia Telangiectasia Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
The Royal Children's Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Amherst, NY
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Boston, MA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Dayton, OH
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Denver, CO
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
East Providence, RI
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Imperial, CA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Media, PA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #10
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #8
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Orlando, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #3
mi
from
Orlando, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 2
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
San Antonio, TX
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
San Diego, CA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #2
mi
from
Springfield, NJ
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Albany, NY
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Bradenton, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Decatur, GA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Houston, TX
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Irvine, CA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Little Rock, AR
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Maitland, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #7
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 3
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #9
mi
from
Miami, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility 1
mi
from
Norristown, PA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
Plains, PA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
West Jordan, UT
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling, Phase III
Updated: 12/31/1969
Facility #1
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Amarillo Hearth Clinical Research Institute, Inc.
mi
from
Amarillo, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Heart and Vascular Institute
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Cardiovascular, LLC
mi
from
Auburn, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiovascular & Vein Center of Florida
mi
from
Bradenton, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Harbor-UCLA Medical Center
mi
from
Carson, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Vincent's Healthcare - Riverside
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Heart & Vascular Associates
mi
from
Kingwood, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
ITB REsearch
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiology Partners Clinical Research Institute
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Louis Heart and Vascular
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Heart House Research Foundation
mi
from
Springfield, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Scott and White Medical Center
mi
from
Temple, TX
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Subjects With NSCLC With an EGFR Activating Mutation Clinical Trial
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
Status: Enrolling, Phase II
Updated: 4/13/2017
US Oncology - Virginia Cancer Specialists, P.C. (VCS)
mi
from
Fairfax, VA
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel
Status: Enrolling, Phase IV
Updated: 3/16/2017
Iraj Sabahi Research Inc
mi
from
Pleasanton, CA
Click here to add this to my saved trials
Cushing Syndrome Clinical Trial
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Royal Bournemouth Hospital
mi
from
Bournemouth,
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ames, IA
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Setauket, NY
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Belvoir, VA
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Radiation Retinopathy Clinical Trial
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Retina Consultants of Houston/Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota | Department of Neurology
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens Hospital of Richmond at Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kane Hall Barry Neurology
mi
from
Bedford, TX
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation; Cleveland Clinic Cancer Center/I40
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Neurology Center of New England
mi
from
Foxboro, MA
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of South Florida - Bradenton
mi
from
Tampa, FL
Click here to add this to my saved trials
Small Bowel Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Emeritas Research Group
mi
from
Lansdowne Town Center, VA
Click here to add this to my saved trials
Small Bowel Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Louisville, Clinical Trials Unit
mi
from
Louisville, KY
Click here to add this to my saved trials
Relapsing, Remitting Multiple Sclerosis Clinical Trial
Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Cincinnati Physicians Company, LLC
mi
from
Dayton, OH
Click here to add this to my saved trials
Axial Spondyloarthritis Clinical Trial
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research - Huntington Beach
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US15
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US05
mi
from
New York, NY
Click here to add this to my saved trials